LESLIE KYRITSES: Open Payments
NPI 1538188362 · ROYAL OAK, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$545 in 18 payments from 3 companies in 2025. Trend: 2023 $924 · 2024 $889 · 2025 $545
Food & beverage: $545
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 7 | $292 |
| Teva Pharmaceuticals USA, Inc. | 8 | $189 |
| ACADIA Pharmaceuticals Inc | 3 | $64 |
Products named: INGREZZA, AUSTEDO XR, NUPLAZID.
Industry payments across MI — which companies pay providers there.
